Rational Design and Synthesis of 4-((1R,2R)-2-Hydroxycyclohexyl)-2(trifluoromethyl)benzonitrile (PF-998425), a Novel, Nonsteroidal Androgen Receptor Antagonist Devoid of Phototoxicity for Dermatological Indications
October 2008
in “
Journal of medicinal chemistry
”
TLDR PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.
The document detailed the rational design and synthesis of PF-998425, a novel, nonsteroidal androgen receptor antagonist intended for dermatological use. The compound was specifically engineered to avoid phototoxicity, a common issue with similar treatments. The research involved multiple departments, including Chemistry, Dermatology Biology, Pharmaceutical Sciences, Pharmacokinetics and Drug Metabolism, and Drug Safety, all within Pfizer Global Research & Development. The study highlighted the collaborative effort across various specialized fields to develop a safer and effective treatment for conditions requiring androgen receptor antagonists.